About the Company
Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SBTX News
Buy Rating on ARS Pharmaceuticals Amid Strong neffy Approval Prospects and Indication Expansion
In a report released on March 21, Roanna Ruiz from Leerink Partners maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research ...
IPO Launch: Silverback Therapeutics Finalizes $125 Million IPO Effort
Silverback Therapeutics (SBTX) aims to raise $125 million from the sale of its common stock in an IPO, according to an amended registration statement. Seattle, Washington-based Silverback was ...
Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M
Local biotech Capstan Therapeutics exceeded its fundraising goal by $50 million despite a tough venture capital environment.
ARS Pharmaceuticals Inc (SPRY)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is ...
Silverback Therapeutics Announces Pricing of Initial Public Offering
Silverback Therapeutics, Inc. (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue ...
Presidio Management Group XII, L.L.C.'s Net Worth
Who is Presidio Management Group XII, L.L.C.? Presidio Management Group XII, L.L.C. has an estimated net worth of $13 Million. This is based on reported shares in Silverback Therapeutics, Inc..
CMPX Compass Therapeutics, Inc.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States.
Omega Therapeutics Inc OMGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Kintara Therapeutics Inc KTRA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
ARS Pharmaceuticals Inc (SPRY)
SAN DIEGO - ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) announced today that its investigational drug neffy, an epinephrine nasal spray, has shown positive results in a phase 2 study ...
Loading the latest forecasts...